Micro- and Nanotechnology in Vaccine Development

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Science & Nature, Technology, Engineering, Chemical & Biochemical
Cover of the book Micro- and Nanotechnology in Vaccine Development by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780323400299
Publisher: Elsevier Science Publication: September 20, 2016
Imprint: Elsevier Language: English
Author:
ISBN: 9780323400299
Publisher: Elsevier Science
Publication: September 20, 2016
Imprint: Elsevier
Language: English

This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress.

MNT allows the creation of particles that exploit the inherent ability of the human immune system to recognize small particles such as viruses and toxins. In combination with minimal protective epitope design, this permits the creation of immunogenic particles that stimulate a response against the targeted pathogen. The finely tuned response of the human immune system to small particles makes it unsurprising that many of the lead adjuvants and vaccine delivery systems currently under investigation are based on nanoparticles.

  • Provides a comprehensive and unparalleled overview of the role of micro- and nanotechnology in vaccine development
  • Allows researchers to quickly familiarize themselves with the broad spectrum of vaccines and how micro- and nanotechnologies are applied to their development
  • Includes a combination of overview chapters setting out general principles, and focused content dealing with specific vaccines, making it useful to readers from a variety of disciplines
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress.

MNT allows the creation of particles that exploit the inherent ability of the human immune system to recognize small particles such as viruses and toxins. In combination with minimal protective epitope design, this permits the creation of immunogenic particles that stimulate a response against the targeted pathogen. The finely tuned response of the human immune system to small particles makes it unsurprising that many of the lead adjuvants and vaccine delivery systems currently under investigation are based on nanoparticles.

More books from Elsevier Science

Cover of the book Principles of Electron Optics, Volume 1 by
Cover of the book Advances in Heterocyclic Chemistry by
Cover of the book Artificial Photosynthesis by
Cover of the book Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases by
Cover of the book Shape Memory Alloys for Biomedical Applications by
Cover of the book Designing Effective Library Tutorials by
Cover of the book Baking Problems Solved by
Cover of the book Digital Signal Processing System Design by
Cover of the book Environment Modeling-Based Requirements Engineering for Software Intensive Systems by
Cover of the book Advances in Applied Microbiology by
Cover of the book Cancer Nanotechnology by
Cover of the book Chemical Finishing of Textiles by
Cover of the book Environmental Engineering and Renewable Energy by
Cover of the book Progress in Optics by
Cover of the book GERD by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy